Kevin Yim won the UZH Entrepreneur Fellowship and joined the UZH IncubatorLab in February 2022. Kevin is focusing on developing a novel modality for rapid non-invasive detection of neonatal disease through liquid biopsies.

Neonatal sepsis is an urgent clinical problem due to the lack of adequate diagnostics. This results in unnecessary and painful interventions, wrong treatments, and high neonatal mortality rates reaching approximately 1.4 million per year. 

Kevin is a Ph.D. student in the Cancer Immunobiology Research Unit at the University of Zürich.